|
PGAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.5166999989269E-08 |
| Normal-vs-Stage3 |
1.95079999931735E-08 |
| Normal-vs-Stage4 |
4.815900E-04 |
| Stage1-vs-Stage2 |
6.484800E-01 |
| Stage1-vs-Stage3 |
2.398200E-01 |
| Stage1-vs-Stage4 |
1.901030E-01 |
| Stage2-vs-Stage3 |
6.286200E-01 |
| Stage2-vs-Stage4 |
4.340000E-01 |
| Stage3-vs-Stage4 |
6.485200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62558855265615E-12 |
| Normal-vs-AfricanAmerican |
1.28290045253721E-10 |
| Normal-vs-Asian |
4.359200E-04 |
| Caucasian-vs-AfricanAmerican |
7.920200E-01 |
| Caucasian-vs-Asian |
7.927200E-01 |
| AfricanAmerican-vs-Asian |
8.753800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
7.3030000002916E-07 |
| Male-vs-Female |
3.431100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.86169999813768E-08 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
1.92919999975061E-08 |
| Normal-vs-Extreme_Obese |
1.85980000289021E-08 |
| Normal_Weight-vs-Extreme_Weight |
3.199500E-02 |
| Normal_Weight-vs-Obese |
7.599600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.263800E-02 |
| Extreme_Weight-vs-Obese |
3.515600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.603600E-01 |
| Obese-vs-Extreme_Obese |
9.202100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.119700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.66133814775094E-16 |
| Normal-vs-Age(61-80Yrs) |
3.88578058618805E-15 |
| Normal-vs-Age(81-100Yrs) |
3.46720000043987E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.338800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.335440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.776550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.288400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.627600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.840600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.63344901441087E-13 |
| Normal-VS-KIRP CIMP |
5.945800E-01 |
| Normal-VS-Unclassified PRCC |
1.13160000037027E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.844400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.912500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.204010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.967800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.346370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.744400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64579461170433E-12 |
| Normal-vs-N1 |
4.304600E-03 |
| Normal-vs-N2 |
6.943600E-03 |
| N0-vs-N1 |
1.213780E-02 |
| N0-vs-N2 |
5.906300E-02 |
| N1-vs-N2 |
7.207800E-01 |
|
|
